DELSTRIGO® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use
offering product urn:matchory:offering:01m772jyzdfspswj687ymaejvq
Offered by Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity). Relation: not stated. Commodity: 51343816 Lamivudine/tenofovir DF (commodity).
An offering's identity is its owner, its commodity and its normalised name; it is never merged with another supplier's.
Facts
| Attribute | Value as written | Producer | Evidence | Observed | Status |
|---|---|---|---|---|---|
| Name as stated name | DELSTRIGO® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use | products products 2 | DELSTRIGO® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral usehttps://www.merck.com/products/ |
2026-11-12 | current |
| Name as stated name | DELSTRIGO® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use | extraction extract 3 | DELSTRIGO® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral usehttps://www.merck.com/products/ |
2026-11-12 | current |
| UNSPSC classification unspsc | 51343816 (8 candidates considered) (0.87) | classification unspsc 3 | 2026-11-12 | current |